CAS: 712313-35-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | HAMI 3379 REF: 3D-MDB31335CAS: 712313-35-4 | Min. 95% | To inquire | Wed 12 Feb 25 |
 | (Rac)-HAMI 3379 REF: TM-T15463CAS: 712313-35-4 | 98% | 583.00 €~2,337.00 € | Wed 19 Feb 25 |
HAMI 3379
Controlled ProductCAS:712313-35-4
HAMI 3379 is a leukotriene receptor antagonist that inhibits the production of TNF-α, a pro-inflammatory …
Formula:
C34H45NO8
Purity:
Min. 95%
Molecular weight:
595.7 g/mol
Ref: 3D-MDB31335
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 12 Feb 2025
(Rac)-HAMI 3379
CAS:712313-35-4
HAMI 3379: potent CysLT2 receptor blocker; protects against acute/subacute brain injury; reduces microglia inflammation.
Formula:
C34H45NO8
Purity:
98%
Color and Shape:
Solid
Molecular weight:
595.72
Ref: TM-T15463
| 25mg | 1,410.00 € | ||
| 50mg | 1,851.00 € | ||
| 100mg | 2,337.00 € |
Estimated delivery in United States, on Wednesday 19 Feb 2025
